Berkshire's Operating Earnings Rose $1.8 Billion Last Quarter. A Currency Swing Was $1.2 Billion of It.

Berkshire Hathaway reported Q2 operating earnings up 16% YoY to $13.0B ($12.98B), but about $1.2B of the increase came from a currency revaluation of non-U.S.-dollar debt (swing from an $877M after-tax loss last year to a $326M gain this year). Excluding the currency effect, operating earnings growth was ~5% (about $12.7B vs ~$12.0B). Manufacturing/service/retail rose 24% to $4.5B, with BHE up 27% to $891M and BNSF up 6% to $1.6B, while underwriting profit fell 13% to $1.7B and insurance investment income fell 9% to $3.1B.

Analysis

The market risk here is not the company itself but the interpretability of the print: a meaningful share of the “earnings beat” is translation noise that can unwind mechanically when FX moves reverse. That matters because BRK.B trades partly as a quality compounder and partly as a quasi-bond proxy; when reported operating growth is inflated by debt revaluation, the multiple can look cheaper than the underlying run-rate, inviting disappointment on the next quarter if the dollar retraces.

Second-order, the softer insurance result is the more important signal for peers than the headline number. Berkshire’s balance sheet can absorb lower underwriting/investment income, but smaller P&C names with less capital flexibility and more reliance on float economics could feel more pressure if premium growth slows or reserve discipline loosens; that points more to selective stock picking inside P&C than a sector-wide read-through. The stronger manufacturing result is a late-cycle datapoint, but it is not enough by itself to justify a broad industrial rotation unless it shows up again next quarter.

The consensus mistake is treating Berkshire as a simple earnings-quality story in either direction. In reality, the stock’s near-term catalyst path is mostly about whether investors look through the accounting lift and focus on the underlying mid-single-digit organic growth, which is solid but not enough to re-rate the name materially. Over 1-3 months, any strength probably fades unless insurance re-accelerates; over 6-18 months, the key risk is that FX and rates swing against the reported optics, compressing sentiment even if fundamentals stay steady.

Key Decisions for Investors

• If BRK.B gaps higher on the headline, fade the move over 1-2 weeks with a small tactical short or call-sale overlay; thesis: reported growth is overstated and likely to mean-revert when FX revaluation normalizes.
• Pair trade: long a best-in-class P&C insurer with stronger underwriting discipline (e.g., CB or PGR) vs short BRK.B for 1-3 months; this isolates true insurance quality from Berkshire’s accounting noise.
• Do not chase BRK.B on this print unless the next quarterly update confirms >5% ex-FX operating growth again; otherwise treat the stock as rangebound and underwhelming versus the broader market.
• Watch the next quarter’s FX and underwriting line items as the falsifier: if the debt revaluation flips negative while insurance stays soft, the earnings narrative should de-rate quickly.